Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination

Indian J Tuberc. 2022 Jul;69(3):369-370. doi: 10.1016/j.ijtb.2022.03.019. Epub 2022 Mar 31.

Abstract

We report an interesting case of an indeterminate MTB QuantiFERON for a 26-year-old healthy soldier planned for a routine field exercise to Brunei. Further medical history revealed that the patient had a Moderna mRNA Covid-19 vaccine the day before his MTB QuantiFERON test. The patient was subsequently asked to repeat a T-spot test which was non-reactive, there were no longer any issues with the positive control for the T-spot test. Current Covid-19 research suggests that infection causes a dysregulation of the immune system, perhaps this might also be extrapolated where a Covid-19 vaccine might provoke an immune response which might interfere with some immunological assays. In summary there should be more research invested into the immunological interactions that the newly developed Covid-19 vaccinations have with our existing immunological tests such as QuantiFERON tests which forms a key cornerstone in our fight against tuberculosis.

Keywords: Moderna; Mycobacterium tuberculosis; QuantiFERON; mRNA Covid-19 vaccination.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273* / administration & dosage
  • 2019-nCoV Vaccine mRNA-1273* / adverse effects
  • Adult
  • COVID-19* / prevention & control
  • False Negative Reactions
  • Humans
  • Mycobacterium tuberculosis
  • Tuberculin Test*
  • Tuberculosis, Lymph Node* / diagnosis
  • Vaccination

Substances

  • 2019-nCoV Vaccine mRNA-1273